Literature DB >> 14639105

Allelic loss of chromosome 6q in gastric carcinoma.

Brenda C Y Li1, Wing Y Chan, Christine Y S Li, Chit Chow, Enders K W Ng, S C Sydney Chung.   

Abstract

Loss of the long arm of chromosome 6 (6q) has frequently been reported in gastric carcinoma, and most gastric cancer patients have evidence of intestinal metaplasia in the stomach. However, the relationship between loss of chromosome 6q and intestinal metaplasia has not been studied. In the first part of the study, we define the critical deletion region of chromosome 6q using loss of heterozygosity technique (LOH). Seventeen microsatellite markers were used to detect loss of heterozygosity (LOH) in 37 microdissected gastric tumors. We also examined intestinal metaplasia (IM) foci of the stomach in the same cancer patient (17 cases). Losses on chromosome 6q were detected in high frequency (51%) by LOH. Two distinct regions of common allelic loss were identified: one centered on the marker D6S300 (at 6q16.1) and the second on D6S446 (at 6q27), with LOH frequency of 36% and 31.3%, respectively. The deletions fall into 2 discrete regions, suggesting the existence of at least 2 tumor suppressor genes in 6q. The losses at 6q27 were confirmed by fluorescence in situ hybridization study (FISH). In the cases with LOH in the tumor, no LOH were detected in the autologous IM areas, but losses were detected by FISH. In some cases, these genetic changes may be acquired in the transition from normal gastric mucosa to intestinal metaplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639105     DOI: 10.1097/00019606-200312000-00003

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  13 in total

1.  Ordered subset analysis identifies loci influencing lung cancer risk on chromosomes 6q and 12q.

Authors:  Shenying Fang; Susan M Pinney; Joan E Bailey-Wilson; Mariza A de Andrade; Yafang Li; Elena Kupert; Ming You; Ann G Schwartz; Ping Yang; Marshall W Anderson; Christopher I Amos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-28       Impact factor: 4.254

2.  DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling.

Authors:  Yuanzi Yu; Wenji Yan; Xuefeng Liu; Yan Jia; Baoping Cao; Yingyan Yu; Youyong Lv; Malcolm V Brock; Jame G Herman; Julien Licchesi; Yunsheng Yang; Mingzhou Guo
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

3.  A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling.

Authors:  Jianchun Wu; Guohua Lei; Mei Mei; Yi Tang; Honglin Li
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

4.  Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.

Authors:  Khelifa Arab; Laura T Smith; Andreas Gast; Dieter Weichenhan; Joseph Po-Hsien Huang; Rainer Claus; Thomas Hielscher; Allan V Espinosa; Matthew D Ringel; Carl D Morrison; Dirk Schadendorf; Rajiv Kumar; Christoph Plass
Journal:  Carcinogenesis       Date:  2011-07-18       Impact factor: 4.944

5.  Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.

Authors:  Xiaomei Zhang; Yunsheng Yang; Xuefeng Liu; James G Herman; Malcolm V Brock; Julien D F Licchesi; Wen Yue; Xuetao Pei; Mingzhou Guo
Journal:  Epigenetics       Date:  2013-02-28       Impact factor: 4.528

6.  Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.

Authors:  Zhiyan Zhao; James G Herman; Malcolm V Brock; Jindong Sheng; Meiying Zhang; Baoguo Liu; Mingzhou Guo
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

Review 7.  Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer.

Authors:  Hee Min Yoo; Jong Ho Park; Young Joo Jeon; Chin Ha Chung
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-20       Impact factor: 5.555

8.  Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.

Authors:  Mitsuro Kanda; Shuji Nomoto; Hisaharu Oya; Ryoji Hashimoto; Hideki Takami; Dai Shimizu; Fuminori Sonohara; Daisuke Kobayashi; Chie Tanaka; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Kenta Murotani; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  J Exp Clin Cancer Res       Date:  2014-10-22

9.  Upregulation of DACT2 suppresses proliferation and enhances apoptosis of glioma cell via inactivation of YAP signaling pathway.

Authors:  Ying Tan; Qiu-Meng Li; Ning Huang; Si Cheng; Guan-Jian Zhao; Hong Chen; Song Chen; Zhao-Hua Tang; Wen-Qian Zhang; Qin Huang; Yuan Cheng
Journal:  Cell Death Dis       Date:  2017-08-10       Impact factor: 8.469

10.  DNA copy number profiles of gastric cancer precursor lesions.

Authors:  Tineke E Buffart; Beatriz Carvalho; Thomas Mons; Rui M Reis; Cátia Moutinho; Paula Silva; Nicole C T van Grieken; Michael Vieth; Manfred Stolte; Cornelis J H van de Velde; Evelin Schrock; Anja Matthaei; Bauke Ylstra; Fátima Carneiro; Gerrit A Meijer
Journal:  BMC Genomics       Date:  2007-10-01       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.